ConductScience.org, home

Paper19085949

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.

Brinker AD and 6 others. Hepatology, 2009. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases. Papers, record 19085949. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19085949

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.
PubMed
Journal
Hepatology
PubMed
Year
2009
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
2.6
iCite
Revised in PubMed
2016-11-24
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brinker ADAllen D
2Wassel RTRonald T
3Lyndly JJenna
4Serrano JJose
5Avigan MMark
6Lee WMWilliam M
7Seeff LBLeonard B

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Chemical and Drug Induced Liver InjuryMajor topic
KetolidesMajor topic
Adult
Aged
Aged, 80 and over
Ascites
Fatal Outcome
Female
Humans
Jaundice
Liver Failure
Male
Middle Aged
Pleural Effusion

Source PubMed

Download CSV of topics

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
38418669Natural Products for the Management of Asthma and COPD.Handb Exp Pharmacol2025https://conductscience.org/library/papers/38418669PubMed
36808265Novel read through agent: ZKN-0013 demonstrates efficacy in APCmin model of familial adenomatous polyposis.J Mol Med (Berl)2023https://conductscience.org/library/papers/36808265PubMed
35188588Impact of novel microbial secondary metabolites on the pharma industry.Appl Microbiol Biotechnol2022https://conductscience.org/library/papers/35188588PubMed
32647996An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids.Drug Saf2020https://conductscience.org/library/papers/32647996PubMed
32019171Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms.Microorganisms2020https://conductscience.org/library/papers/32019171PubMed
30992910Causality assessment: Which is best-expert opinion or RUCAM?Clin Liver Dis (Hoboken)2014https://conductscience.org/library/papers/30992910PubMed
30734107Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling.Pharm Res2019https://conductscience.org/library/papers/30734107PubMed
28971877In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28971877PubMed
28443154Drug-induced liver injury: Do we know everything?World J Hepatol2017https://conductscience.org/library/papers/28443154PubMed
28314920[New antibiotics - standstill or progress].Med Klin Intensivmed Notfmed2017https://conductscience.org/library/papers/28314920PubMed
27909995Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.Drugs2016https://conductscience.org/library/papers/27909995PubMed
27353268Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27353268PubMed
27000559Targeting Antibiotic Resistance.Angew Chem Int Ed Engl2016https://conductscience.org/library/papers/27000559PubMed
26633044Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Expert Rev Gastroenterol Hepatol2016https://conductscience.org/library/papers/26633044PubMed
26524373[Advancement in chronic drug-induced liver injury].Zhonghua Gan Zang Bing Za Zhi2015https://conductscience.org/library/papers/26524373PubMed
26167249Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.World J Hepatol2015https://conductscience.org/library/papers/26167249PubMed
25232453Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database.World J Hepatol2014https://conductscience.org/library/papers/25232453PubMed
25086050"First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.Am J Epidemiol2014https://conductscience.org/library/papers/25086050PubMed
24379197In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24379197PubMed
24178291Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.Drug Saf2013https://conductscience.org/library/papers/24178291PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19085949

GET https://conductscience.org/api/papers/v1/19085949/cited_by?page=2